Macron headed for overwhelming parliamentary majority

Agencies
June 12, 2017

Paris, June 12: French President Emmanuel Macron’s party is on course for an overwhelming parliamentary majority after Sunday’s first round of voting for the National Assembly that left traditional parties in disarray.

Macron

Forecasts based on partial results showed Macron continuing his centrist revolution, with his Republique en Marche party (Republic on the Move, REM) and its ally MoDem tipped to win between 390 and 445 seats in the 577—member National Assembly in next Sunday’s second round.

“France is back,” Prime Minister Edouard Philippe declared triumphantly.

“For the past month, the President has shown confidence, willingness and daring in France and on the international stage,” Mr. Philippe said, calling the result a vindication of Mr. Macron’s “winning strategy”.

The vote was marked by record low turnout of 49 per cent, reflecting the fatalism among Macron’s opponents in the face of his seemingly unstoppable advance, experts said.

The right-wing Republicans —— who had hoped to rebound from their defeat in the presidential vote —— were shown trailing in second with a predicted 80—132 seats while Marine Le Pen’s far—right National Front (FN) was forecast to garner between one and 10 seats.

The FN’s result showed the party struggling to rebound from Ms. Le Pen’s bruising defeat by Mr. Macron in the presidential run-off.

FN vice-president Florian Philippot admitted to “disappointment” and called on voters to “mobilise massively” for the June 18 second round.

The worst losses, however, were for the Socialists of Mr. Macron’s predecessor Francois Hollande, who were shown dropping a staggering 200 seats.

Conceding the party was facing “unprecedented” losses, PS chief Jean-Christophe Cambadelis appealed to voters to rally behind Mr. Macron’s rivals to avoid the President monopolising power.

Parliament risked having “no real oversight powers and no democratic debate worth speaking of,” he warned.

Republicans leader Francois Baroin also cautioned against all the power being “concentrated in one party”.

The estimates based on partial results showed Mr. Macron’s year-old REM and MoDem winning 32.2—32.9 per cent in the first round, ahead of the Republicans on 20.9—21.5 per cent and the FN on 13.1—14 per cent.

Few MPs are expected to be elected outright on Sunday.

If no candidate wins over 50 percent, the two top-placed contenders go into the second round —— along with any other candidate who garners at least 12.5 per cent of registered voters.

France’s youngest-ever President has been credited with restoring a lost sense of national pride since winning the top office last month at 39.

He has won praise for appointing a balanced cabinet that straddles France’s long-entrenched left-right divide and taking a leading role in Europe’s fight-back against US President Donald Trump on climate change.

If the seat projections are confirmed next week, he will have a strong mandate to push through the ambitious labour, economic and social reforms he promised on the campaign trail.

More than 50,000 police were on patrol during the vote, with France still jittery after a wave of jihadist attacks at home and across the Channel in Britain.

Mr. Macron, who had never held elected office before becoming President, fielded political novices in around 200 constituencies —— part of his bid to rejuvenate the assembly.

They include Marie Sara, a retired bullfighter, who is taking on FN stalwart Gilbert Collard in southern France and 33-year-old junior digital economy minister Mounir Mahjoubi who went up against PS boss Cambadelis in northeast Paris.

Mr. Macron is also trying to usher in an era of cleaner politics. His government’s first bill proposes to ban lawmakers from employing family members or performing consultancy work while in office.

The measures follow the scandal that destroyed the presidential bid of Republicans candidate Francois Fillon, who has been charged over payments to his wife and two of his children for suspected fake jobs as parliamentary assistants.

Mr. Fillon denies the charges.

Mr. Macron’s party has largely avoided controversy but one of his ministers who is running for re-election in Brittany, Richard Ferrand, is being probed over a property deal involving his girlfriend.

Forecasts show Le Pen’s party will struggle to win the 15 seats it would need to form a parliamentary group and help shape the assembly’s agenda.

The radical-left France Insoumise (France Unbowed) party of Jean-Luc Melenchon who finished fourth in the presidential race also fell short of expectations.

His camp was tipped to only take 10—23 seats.

Mr. Macron has urged voters to back his reform proposals including an overhaul of the rigid rules governing the job market, blamed by many economists for holding back growth.

The President was economy minister in the Socialist government that began loosening the labour laws last year, sparking mass demonstrations that lasted for months.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Russia boasts that it's about to become the first country to approve a Covid-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire.

Moscow sees a Sputnik-like propaganda victory, recalling the Soviet Union's launch of the world's first satellite in 1957.

But the experimental Covid-19 shots began first-in-human testing on a few dozen people less than two months ago, and there's no published scientific evidence yet backing Russia's late entry to the global vaccine race, much less explaining why it should be considered a front-runner.

“I'm worried that Russia is cutting corners so that the vaccine that will come out may be not just ineffective, but also unsafe,” said Lawrence Gostin, a global public health law expert at Georgetown University. “It doesn't work that way... Trials come first. That's really important.”

According to Kirill Dmitriev, head of Russia's Direct Investment Fund that bankrolled the effort, a vaccine developed by the Gamaleya research institute in Moscow may be approved in days, before scientists complete what's called a Phase 3 study.

That final-stage study, usually involving tens of thousands of people, is the only way to prove if an experimental vaccine is safe and really works.

Health Minister Mikhail Murashko said members of “risk groups,” such as medical workers, may be offered the vaccine this month.

He didn't clarify whether they would be part of the Phase 3 study that is said to be completed after the vaccine receives “conditional approval.”

Deputy Prime Minister Tatyana Golikova promised to start “industrial production” in September, and Murashko said mass vaccination may begin as early as October.

Dr Anthony Fauci, the top US infectious disease specialist, questioned the fast-track approach last week.

“I do hope that the Chinese and the Russians are actually testing a vaccine before they are administering the vaccine to anyone, because claims of having a vaccine ready to distribute before you do testing I think is problematic at best," he said.

Questions about this vaccine candidate come after the US, Britain and Canada last month accused Russia of using hackers to steal vaccine research from Western labs.

Delivering a vaccine first is a matter of national prestige for the Kremlin as it tries to assert the image of Russia as a global power capable of competing with the US and China.

The notion of being “the first in the world” dominated state news coverage of the effort, with government officials praising reports of the first-step testing.

In April, President Vladimir Putin ordered state officials to shorten the time of clinical trials for a variety of drugs, including potential coronavirus vaccines.

According to Russia's Association of Clinical Trials Organizations, the order set “an unattainable bar” for scientists who, as a result, "joined in on the mad race, hoping to please those at power.”

The association first raised concern in late May, when professor Alexander Gintsburg, head of the Gamaleya institute, said he and other researchers tried the vaccine on themselves.

The move was a “crude violation of the very foundations of clinical research, Russian law and universally accepted international regulations" the group said in an open letter to the government, urging scientists and health officials to adhere to clinical research standards.

But a month later, the Health Ministry authorized clinical trials of the Gamaleya product, with what appeared to be another ethical issue.

Human studies started June 17 among 76 volunteers. Half were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder.

Some in the first half were recruited from the military, which raised concerns that servicemen may have been pressured to participate.

Some experts said their desire to perform well would affect the findings. “It's no coincidence media reports we see about the trials among the military said no one had any side effects, while the (other group) reported some," said Vasily Vlassov, a public health expert with Moscow's Higher School of Economics.

As the trials were declared completed and looming regulatory approval was announced last week, questions arose about the vaccine's safety and effectiveness.

Government assurances the drug produced the desired immune response and caused no significant side effects were hardly convincing without published scientific data describing the findings.

The World Health Organization said all vaccine candidates should go through full stages of testing before being rolled out.

“There are established practices and there are guidelines out,” WHO spokesman Christian Lindmeier said Tuesday.

“Between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages, is a big difference.”

Offering an unsafe compound to medical workers on the front lines of the outbreak could make things worse, Georgetown's Gostin said, adding: “What if the vaccine started killing them or making them very ill?”

Vaccines that are not properly tested can cause harm in many ways — from a negative impact on health to creating a false sense of security or undermining trust in vaccinations, said Thomas Bollyky, director of the global health program at the Council on Foreign Relations. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 26,2020

Washington, Jun 26: The US is reviewing its global deployment of forces to ensure it is postured appropriately to counter the People's Liberation Army, given the increasing threat posed by China to Asian countries like India, Malaysia, Indonesia, and the Philippines, Secretary of State Mike Pompeo said on Thursday.

Mr Pompeo made those remarks in response to a question during the virtual Brussels Forum 2020 of the German Marshall Fund.

"We're going to make sure we're postured appropriately to counter the PLA. We think that the challenge of our times, and we're going to make sure we have resources in place to do that," Mr Pompeo said.
 
The force posture review is being done at the direction of President Donald Trump, as part of which the US is reducing the number of its troops in Germany from about 52,000 to 25,000, he said.

Mike Pompeo said that the force posture would be dictated by the ground realities.

"In certain places there will be fewer American resources. There'll be other places - I just talked about the threat from the Chinese Communist Party, so now threats to India, threats to Vietnam, threats to Malaysia, Indonesia, South China Sea challenges, the Philippines," he said.

"To the extent that that changed, the difference in what the US decided to do impacts adversely a threat some place, it may be that other nations need to step up and take responsibility for their own defense in ways that they hadn't done previously. So, we want to do this in full consultation with all of our partners all around the world, and certainly our friends in Europe," Mr Pompeo said.

President Trump is being criticised for reducing troops from Germany. His critics say that this will increase the threat from Russia to Europe.

Mike Pompeo, however, did not agree with that argument.

It has been a long time since there has been a strategic review of our force posture all across the world. The US undertook that starting about 2.5 years ago, whether that was our forces in Africa, our forces in Asia, the force we have in the Middle East and in Europe, he said.

"We began to say these are often decisions that were made in a different time. Should we reallocate those a different way? Should we have a different composition of those forces? Everyone always wants to talk about ground troops. I get it. I was a young tank officer. You described that. There's nothing I like as much as a good M1 tank.

"But it's often the case that the capacity to deter Russia or other adversaries isn''t determined any longer by just having a bunch of folks garrisoned someplace. So, we really went to back fundamentally relook, what is the nature of the conflict, what''s the nature of the threat, and how should we allocate our resources, whether that''s our resources in the intelligence community, our resources from the Air Force or the Marines and Army," Mr Pompeo said.

Last week, Mike Pompeo criticised the Chinese Army for "escalating" the border tension with India and militarising the strategic South China Sea. He also described the ruling Communist Party of China (CPC) as a "rogue actor".

"Our broad set of allocation of security apparatus, our ability to counter cyber threats, how do we allocate them? What''s the best way to do this? And the decision that you see the president made with respect to Germany is an outcome from a collective set of decisions about how we''re going to posture our resources around the world," said the top American diplomat on Thursday.

Changes in force posture is being taken in consultations with allies and friends, Mr Pompeo said.

"President Trump has spoken to this. (Defense) Secretary (Mark) Esper will be in London today and in Brussels tomorrow. We''ll talk about our plan and how we''re thinking about delivering it," he said.

"But you should understand this, and I hope our European partners will understand this as well. When you see what we ultimately conclude, how we ultimately deliver on the statements of the president made, that they''re aimed squarely at what we believe to be democracies'' fundamental interest and certainly America's most fundamental interest," Mr Pompeo said.

Earlier this month, Mike Pompeo had said that China's actions, be it on the India border, or in Hong Kong or in the South China Sea, were part of the behaviour of the ruling Communist Party in Beijing in the recent past.

China has been fast expanding military and economic influence in the Indo-Pacific region, triggering concern in various countries of the region and beyond.

China is engaged in hotly contested territorial disputes in both the South China Sea and the East China Sea. Beijing has built up and militarised many of the islands and reefs it controls in the region. Both areas are stated to be rich in minerals, oil and other natural resources and are vital to global trade.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Hubei, Mar 25: As a bus departed from its terminus at Hankou Railway Station at 5:25 am Wednesday morning, Wuhan started to resume bus service after nine weeks of lockdown.

Apart from a driver, a safety supervisor was also on each bus, whose duty was to make sure all passengers are healthy.
"For those who do not use smartphones, they should bring with them a health certificate issued by the health authorities," said Zhou Jingjing, a safety supervisor aboard bus No. 511 departing from the Wuchang Railway Station complex.
The once hardest-hit city in central China's Hubei Province during the COVID-19 outbreak took unprecedented traffic restrictions on Jan 23. All of its public transport and all outbound flights and trains had been suspended in an attempt to contain the virus within the region.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.